green tea and glutathione Matcha & Facial Deep Cleanser with Ceramide & Hyaluronic Acid A Comparative Study on the

Key takeaways Animal studies show BPC-157 improves gastric motility and protects against gastric damage in rats No human clinical trial has tested BPC-157 for gastroparesis specifically BPC-157 modulates the nitric oxide system and may interact with vagal nerve function, both relevant to gastroparesis Oral administration (250-500 mcg daily) is preferred over injection for GI-targeted effects BPC-157 is unusually stable in stomach acid, making oral delivery viable Patients should work with their gastroenterologist before adding BPC-157 to their gastroparesis management What is gastroparesis and why is it hard to treat

Median (interquartile range) age was 55.0 (47.0-62.0) years and 73% were men

Materials and Methods Chemicals All chemicals and reagents used in this study were of molecular and analytical grade and were purchased from Sigma Chemical Co

doi:10.1105/tpc.11.6.1153